The primary endpoint was significantly reduced by prasugrel in the overall NSTE-ACS population ( hazard ratio ( HR ) @ , @ % confidence interval ( CI ) @-@ @ , p = @ ) as well as in unstable angina ( UA ) and in non-ST elevation myocardial infarction ( NSTEMI ) patient subgroups ( interaction p value = @ ) .